Product image of Glucagon Novo Nordisk (Glucagon) supplied by GNH India

Glucagon Novo Nordisk

Active Ingredient:
Glucagon
Origin:
EU

Glucagon Novo Nordisk (Glucagon)

Glucagon Novo Nordisk is a prescription injectable medication that contains the hormone glucagon as its sole active ingredient. It is supplied in a sterile solution for intramuscular, intravenous, or subcutaneous administration. The product is marketed in the European Union and belongs to the hormone drug class, specifically classified as an antihypoglycemic agent used to raise blood glucose levels during severe hypoglycemia in emergency situations for patients.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucagon Novo Nordisk is indicated for the rapid treatment of severe hypoglycemia when oral glucose administration is not feasible.

  • Acute management of insulin‑induced hypoglycemia in adults and children.
  • Emergency reversal of hypoglycemia in patients with diabetes mellitus.
  • Use when a patient is unconscious, unable to swallow, or has seizures due to low blood sugar.
  • Administration by trained healthcare professionals or caregivers in a crisis situation.

Side Effects

The safety profile of Glucagon Novo Nordisk includes both frequently observed and rare but serious adverse reactions.

Common

  • Nausea or vomiting.
  • Flushing or warmth at the injection site.
  • Headache.
  • Transient rise in blood pressure.

Serious

  • Severe allergic reaction (anaphylaxis) with rash, itching, or swelling.
  • Cardiac arrhythmia or palpitations.
  • Hypotension or shock in rare cases.

Precautions & Warnings

Before using Glucagon Novo Nordisk, certain precautions should be considered to ensure safe administration.

  • Verify the diagnosis of severe hypoglycemia and confirm that oral glucose is not possible.
  • Use only with a sterile, unopened cartridge or vial; discard any product that appears discolored or contains particles.
  • Assess for a history of adrenal or pituitary insufficiency, as glucagon may be less effective.
  • Monitor cardiovascular status, especially in patients with known heart disease.
  • Avoid repeat dosing within 24 hours unless directed by a healthcare professional.
  • Keep the medication out of reach of children and store according to label instructions.

Avoid Interactions

Glucagon Novo Nordisk may interact with other medicines; understanding these interactions helps prevent reduced efficacy or increased risk.

Avoid

  • Beta‑blockers, which can blunt the glucose‑raising response.
  • Insulin or other antihyperglycemic agents given shortly before glucagon, increasing risk of rebound hyperglycemia.

Use with caution

  • Catecholamine‑releasing drugs (e.g., epinephrine) that may amplify cardiovascular effects.
  • Oral contraceptives or hormone therapies that could affect glucose metabolism.
  • Certain diuretics that influence electrolyte balance.

Frequently Asked Questions

Glucagon Novo Nordisk is an injectable formulation of the hormone glucagon. It raises blood glucose by stimulating hepatic glycogenolysis and gluconeogenesis, providing a rapid increase in glucose during severe hypoglycemia.

It should be given when a person with diabetes experiences severe hypoglycemia that cannot be treated with oral glucose, such as when the individual is unconscious, having seizures, or unable to swallow.

Yes, trained caregivers may administer the injection to children under the guidance of a healthcare professional, following the prescribed emergency protocol.

Common reactions include nausea, vomiting, flushing or warmth at the injection site, headache, and a temporary rise in blood pressure.

The product is supplied as a sterile injectable solution in a cartridge or vial. It should be stored according to the label, typically refrigerated, and protected from light.

Glucagon is contraindicated in individuals with known hypersensitivity to glucagon or any component of the formulation.

Beta‑blockers should be avoided because they may reduce glucagon’s glucose‑raising effect, and concurrent insulin may increase the risk of rebound hyperglycemia.

Glucagon works systemically to stimulate glucose production in the liver, making it effective when oral glucose cannot be absorbed, whereas oral glucose relies on gastrointestinal absorption.

After administration, blood glucose should be re‑checked to confirm a rise, and the patient should be observed for any adverse reactions, especially cardiovascular changes.

No, Glucagon Novo Nordisk is a prescription‑only medication in the European Union and must be prescribed by a qualified healthcare professional.

Blood glucose typically begins to rise within 5 to 10 minutes after an intramuscular, intravenous, or subcutaneous injection.

If glucose does not increase, a second dose may be administered after 15 minutes under medical supervision, and emergency medical services should be contacted immediately.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glucagon

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT